ISSN: 1871-6784

Journal Home

Journal Guideline

New Biotechnology Q1 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

New Biotechnology is a journal indexed in SJR in Molecular Biology and Medicine (miscellaneous) with an H index of 105. It has an SJR impact factor of 0,888 and it has a best quartile of Q1. It has an SJR impact factor of 0,888.

New Biotechnology focuses its scope in these topics and keywords: antibody, medicine, malaysia, lipid, librariesthe, landscape, igg, highthroughput, heke, membrane, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Bioengineering (Q2) Biotechnology (Q2) Molecular Biology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,888

SJR Impact factor

105

H Index

61

Total Docs (Last Year)

217

Total Docs (3 years)

3422

Total Refs

1181

Total Cites (3 years)

213

Citable Docs (3 years)

5.28

Cites/Doc (2 years)

56.1

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Research Q1
Molecular Cell Q1
Cell Host and Microbe Q1
Annual Review of Plant Biology Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Design-of-experiment strategy for the formulation of laccase biocatalysts and their application to degrade bisphenol A

Metabolic profiling of hematopoietic stem and progenitor cells during proliferation and differentiation into red blood cells

Improving field production of ergot alkaloids by application of gametocide on rye host plants

Production of nattokinase by batch and fed-batch culture of Bacillus subtilis

Proteomics of survival structures of fungal pathogens

Reprint of "iPSCs, aging and age-related diseases"

How to systematically evaluate immunogenicity of therapeutic proteins -regulatory considerations

Aqueous biphasic treatment of some nitrocompounds with hydrogen in the presence of a biogenerated Pd-polysaccharide

The 6th International Conference on Analysis of Microbial Cells at the Single Cell Level, Retz, Austria, 19-22 July 2015

Isolation and characterization of a novel thermostable a-amylase from Korean pine seeds

Formation of acrylamide from glucans and asparagine

Approaching marine bioprospecting in hexacorals by RNA deep sequencing

SHOW MORE ARTICLES

Acute but not chronic exposure to abiotic stress results in transient reduction of expression levels of the transgene driven by the 35S promoter

Ammoniacal nitrogen removal in wastewater using nitrifying and denitrifying bacteria in a SBR system

A comparison of phosphospecific affinity reagents reveals the utility of recombinant Forkhead-associated domains in recognizing phosphothreonine-containing peptides

Purification, characterization and identification of a novel bifunctional catalase-phenol oxidase from Scytalidium thermophilum

Levansucrases of a Pseudomonas syringae pathovar as catalysts for the synthesis of potentially prebiotic oligo- and polysaccharides

Effect of the pH on growth and esterase activity of Fusarium culmorum grown on media supplemented with di (2-ethylhexyl) phthalate in submerged fermentation

Ammonium nitrate improves direct somatic embryogenesis and biolistic transformation of Triticum aestivum

The Saccharomyces cerevisiae YMR315W gene encodes an NADP(H)-specific oxidoreductase regulated by the transcription factor Stb5p in response to NADPH limitation

Application of a molecular based approach for the early detection of short term 3-chloroaniline shock loads on activated sludge bacterial community and functionality

Strategies to identify microRNA targets: New advances

High precision quantification of human plasma proteins using the automated SISCAPA Immuno-MS workflow

Explaining the present GM business strategy on the EU food market: The gatekeepers' perspective